Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer. (3rd April 2021) - Bregni, Giacomo; Vandeputte, Caroline; Pretta, Andrea; Senti, Chiara; Trevisi, Elena; Acedo Reina, Elena; Kehagias, Pashalina; Liberale, Gabriel; Moretti, Luigi; Bali, Maria Antonietta; Demetter, Pieter; Flamen, Patrick; et al.